Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact
Search
Close
Enter Search Terms
Search
Molly Grammel
ID:
1b83b168-2619-30fb-68c4
/
Unclaimed
/
Organization:
Goodwin Procter
Published Works
7 articles
Regeneron Files First BPCIA Complaint Regarding Biosimilar Eylea against Mylan in West Virginia District Court
Big Molecule Watch ·
August 3, 2022
cite
CA Gov. Newsom Announces Budget Approval for Biosimilar Insulin Initiative
Big Molecule Watch ·
July 13, 2022
cite
Previous
1
2
Next
